Syngene to acquire multi-modal facility from Stelis Biopharma Ltd, adding 20,000 liters of installed biologics drug substance manufacturing capacity, with scope for further expansion, and a high speed, commercial scale, fill-finish unit

webmaster Wednesday, July 05, 2023

Jobs

Indian IT is ageing, investors should cut expectations from them: Damodaran

webmaster Saturday, January 28, 2017

your

Libra yearly horoscope for 2025

webmaster Tuesday, November 26, 2024

Virginia

Are SIPs the risk-free formula for making money?

webmaster Sunday, January 29, 2017